David FABRIZIO

Person

South Hamilton, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
PET imaging with PD-L1 binding polypeptides
- Patent number 11,344,639
- Issue date May 31, 2022
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serum albumin-binding fibronectin type III domains
- Patent number 11,203,630
- Issue date Dec 21, 2021
- Bristol-Myers Squibb Company
- Tracy S. Mitchell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-L1 binding polypeptides for imaging
- Patent number 11,173,219
- Issue date Nov 16, 2021
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted therapeutics based on engineered proteins for tyrosine kin...
- Patent number 11,149,077
- Issue date Oct 19, 2021
- Bristol-Myers Squibb Company
- Ray Camphausen
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Serum albumin binding molecules
- Patent number 10,934,572
- Issue date Mar 2, 2021
- Bristol-Myers Squibb Company
- Michael L. Gosselin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeted therapeutics based on engineered proteins that bind EGFR
- Patent number 10,781,247
- Issue date Sep 22, 2020
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serum albumin-binding fibronectin type III domains
- Patent number 10,442,851
- Issue date Oct 15, 2019
- Bristol-Myers Squibb Company
- Tracy S. Mitchell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-L1 binding polypeptides for imaging
- Patent number 10,406,251
- Issue date Sep 10, 2019
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating cancer by administering IGF-IR binding molecules
- Patent number 10,221,232
- Issue date Mar 5, 2019
- Bristol-Myers Squibb Company
- Ray Camphausen
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Serum albumin binding molecules
- Patent number 10,221,438
- Issue date Mar 5, 2019
- Bristol-Myers Squibb Company
- Michael L. Gosselin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeted therapeutics based on engineered proteins that bind EGFR
- Patent number 9,920,108
- Issue date Mar 20, 2018
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serum albumin binding molecules
- Patent number 9,540,424
- Issue date Jan 10, 2017
- Bristol-Myers Squibb Company
- Michael L. Gosselin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted therapeutics based on engineered proteins that bind EGFR
- Patent number 9,234,028
- Issue date Jan 12, 2016
- Bristol-Myers Squibb Company
- Ray Camphausen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Serum albumin binding molecules
- Patent number 8,969,289
- Issue date Mar 3, 2015
- Bristol-Myers Squibb Company
- Michael L. Gosselin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted therapeutics based on engineered proteins that bind EGFR
- Patent number 8,524,244
- Issue date Sep 3, 2013
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted therapeutics based on engineered proteins for tyrosine kin...
- Patent number 8,470,332
- Issue date Jun 25, 2013
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES
- Publication number 20220347324
- Publication date Nov 3, 2022
- Bristol-Myers Squibb Company
- Paul E. MORIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20220204589
- Publication date Jun 30, 2022
- Bristol-Myers Squibb Company
- Tracy S. MITCHELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING
- Publication number 20220001040
- Publication date Jan 6, 2022
- Bristol-Myers Squibb Company
- Paul E. MORIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR
- Publication number 20210040181
- Publication date Feb 11, 2021
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20200048328
- Publication date Feb 13, 2020
- Bristol-Myers Squibb Company
- Tracy S. MITCHELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING
- Publication number 20190343972
- Publication date Nov 14, 2019
- Bristol-Myers Squibb Company
- Paul E. MORIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...
- Publication number 20190202894
- Publication date Jul 4, 2019
- Bristol-Myers Squibb Company
- Ray CAMPHAUSEN
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
SERUM ALBUMIN BINDING MOLECULES
- Publication number 20190203248
- Publication date Jul 4, 2019
- Bristol-Myers Squibb Company
- Michael L. GOSSELIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES
- Publication number 20190184042
- Publication date Jun 20, 2019
- Bristol-Myers Squibb Company
- Paul E. MORIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR
- Publication number 20180244755
- Publication date Aug 30, 2018
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING
- Publication number 20170258948
- Publication date Sep 14, 2017
- Bristol-Myers Squibb Company
- Paul E. MORIN
- G01 - MEASURING TESTING
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...
- Publication number 20170190761
- Publication date Jul 6, 2017
- Bristol-Myers Squibb Company
- Ray CAMPHAUSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20170174748
- Publication date Jun 22, 2017
- Bristol-Myers Squibb Company
- Tracy S. MITCHELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SERUM ALBUMIN BINDING MOLECULES
- Publication number 20170145464
- Publication date May 25, 2017
- Bristol-Myers Squibb Company
- Michael L. GOSSELIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR
- Publication number 20160152688
- Publication date Jun 2, 2016
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...
- Publication number 20150252097
- Publication date Sep 10, 2015
- Bristol-Myers Squibb Company
- Ray CAMPHAUSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SERUM ALBUMIN BINDING MOLECULES
- Publication number 20150152147
- Publication date Jun 4, 2015
- Bristol-Myers Squibb Company
- Michael L. GOSSELIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR ACCELERATED SELECTION OF POLYPEPTIDES
- Publication number 20140256589
- Publication date Sep 11, 2014
- David A. Fabrizio
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR
- Publication number 20140038893
- Publication date Feb 6, 2014
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...
- Publication number 20130310317
- Publication date Nov 21, 2013
- Bristol-Myers Squibb Company
- Ray CAMPHAUSEN
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
SERUM ALBUMIN BINDING MOLECULES
- Publication number 20110305663
- Publication date Dec 15, 2011
- Bristol-Myers Squibb Company
- Michael L. Gosselin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR
- Publication number 20110053842
- Publication date Mar 3, 2011
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...
- Publication number 20100121033
- Publication date May 13, 2010
- Bristol-Myers Squibb Company
- Ray Camphausen
- C40 - COMBINATORIAL CHEMISTRY

David FABRIZIO

Person

Patents Grantslast 30 patents

PET imaging with PD-L1 binding polypeptides

Serum albumin-binding fibronectin type III domains

PD-L1 binding polypeptides for imaging

Targeted therapeutics based on engineered proteins for tyrosine kin...

Serum albumin binding molecules

Targeted therapeutics based on engineered proteins that bind EGFR

Serum albumin-binding fibronectin type III domains

PD-L1 binding polypeptides for imaging

Methods of treating cancer by administering IGF-IR binding molecules

Serum albumin binding molecules

Targeted therapeutics based on engineered proteins that bind EGFR

Serum albumin binding molecules

Targeted therapeutics based on engineered proteins that bind EGFR

Serum albumin binding molecules

Targeted therapeutics based on engineered proteins that bind EGFR

Targeted therapeutics based on engineered proteins for tyrosine kin...

Patents Applicationslast 30 patents

PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES

SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS

NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR

SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS

NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...

SERUM ALBUMIN BINDING MOLECULES

PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR

NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...

SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS

SERUM ALBUMIN BINDING MOLECULES

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...

SERUM ALBUMIN BINDING MOLECULES

METHODS FOR ACCELERATED SELECTION OF POLYPEPTIDES

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...

SERUM ALBUMIN BINDING MOLECULES

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KIN...